CAS No.
[116680-01-4 (Unlabeled)]
Therapeutic Uses
Immunosuppressants
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(E)-2-morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate hydrochloride-d4
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Mycophenolate Mofetil-d4 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Mycophenolate Mofetil-d4 Hydrochloride usage and description
Mycophenolate Mofetil Hydrochloride D4 is a stable isotopic labeled form of Mycophenolate Mofetil, which belongs to a class of drugs known as immunosuppressants. It is used to prevent rejection of transplanted organs or tissues in patients who have undergone organ transplant surgery.
Mycophenolate Mofetil Hydrochloride D4 works by inhibiting the proliferation of T and B lymphocytes, which are the cells responsible for rejecting foreign tissues in the body. It does this by blocking the activity of an enzyme called inosine monophosphate dehydrogenase (IMPDH), which is required for the synthesis of DNA in these cells.
Chemically, Mycophenolate Mofetil Hydrochloride D4 is a prodrug that is rapidly metabolized in the body to form mycophenolic acid, which is the active ingredient responsible for its immunosuppressive effects. The presence of deuterium atoms in the molecule of Mycophenolate Mofetil Hydrochloride D4 does not alter the pharmacological properties of the drug, but it is used as a marker for pharmacokinetic studies and to differentiate it from the non-labeled drug.
Mycophenolate Mofetil Hydrochloride D4 is available in the form of tablets or capsules for oral administration. The recommended dose and duration of treatment varies depending on the type of transplant, the patient's age and weight, and other factors. Common side effects of Mycophenolate Mofetil Hydrochloride D4 include gastrointestinal disturbances, infections, anemia, and leukopenia. It is important to adhere to the prescribed dosage and follow-up appointments with the healthcare provider to monitor the effectiveness and safety of the drug.
